Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rebecca J. Grant-Klein
Observed names:
Grant-Klein, Rebecca J.,
Rebecca Grant-Klein,
Rebecca J Grant-Klein
Institution:
Merck & Co., Inc., Rahway, NJ, USA (United States)
Observed institutions:
Merck & Co., Inc., Rahway, NJ, USA (United States),
United States Army Medical Research Institute of Infectious Diseases
OpenAlex ID:
A5031908285
Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges
2015
·
Rebecca J Grant-Klein
, Louis A Altamura
, et al.
·
Human Vaccines & Immunotherapeutics
·
75
PDF
Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults
2019
·
Scott A Halperin
, Rituparna Das
, et al.
·
The Journal of Infectious Diseases
·
54
PDF
Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic
2017
·
Beth-Ann G. Coller
, Jeffrey Blue
, et al.
·
Vaccine
·
49
A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge
2012
·
Rebecca J. Grant-Klein
, Nicole M. Van Deusen
, et al.
·
Human Vaccines & Immunotherapeutics
·
46
PDF
Rapid identification of vector-borne flaviviruses by mass spectrometry
2010
·
Rebecca J. Grant-Klein
, Carson D. Baldwin
, et al.
·
Molecular and Cellular Probes
·
42
Estimation of the correlates of protection of the rVSVΔG-ZEBOV-GP Zaire ebolavirus vaccine: a post-hoc analysis of data from phase 2/3 clinical trials
2021
·
Rebecca F Grais
, Stephen B Kennedy
, et al.
·
The Lancet Microbe
·
35
PDF
Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses
2011
·
Rebecca J. Grant-Klein
, Louis A. Altamura
, et al.
·
Virus Research
·
33
Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials
2022
·
Jakub K. Simon
, Stephen B. Kennedy
, et al.
·
Vaccine
·
26
Development and Validation of a Sensitive and Robust Multiplex Antigen Capture Assay to Quantify Streptococcus pneumoniae Serotype-Specific Capsular Polysaccharides in Urine
2022
·
Gowrisankar Rajam
, Yuhua Zhang
, et al.
·
mSphere
·
18
Serostatus cutoff levels and fold increase to define seroresponse to recombinant vesicular stomatitis virus – Zaire Ebola virus envelope glycoprotein vaccine: An evidence-based analysis
2020
·
Joseph Antonello
, Rebecca J. Grant-Klein
, et al.
·
Vaccine
·
17
Effect of Gamma Irradiation on the Antibody Response Measured in Human Serum from Subjects Vaccinated with Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein Vaccine
2019
·
Rebecca J. Grant-Klein
, Joseph Antonello
, et al.
·
American Journal of Tropical Medicine and Hygiene
·
14
PDF
Effects of Gamma Irradiation of Human Serum Samples from rVSVΔG-ZEBOV-GP (V920) Ebola Virus Vaccine Recipients on Plaque-Reduction Neutralization Assays
2021
·
Rebecca J. Grant-Klein
, Joseph Antonello
, et al.
·
American Journal of Tropical Medicine and Hygiene
·
3
28. Immunogenicity of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO™) in Participants by Age, Sex, and Baseline GP-ELISA Titer: A Post Hoc Analysis of Three Phase 2/3 Trials
2020
·
Jakub Simon
, Stephen Kennedy
, et al.
·
Open Forum Infectious Diseases
Show more works
View as search
Works count:
14
Citation count:
412
H-index:
11
I10-index:
11
Year
Topic
Type
